187 related articles for article (PubMed ID: 6696460)
41. High concentrations of activin A in the peritoneal fluid of women with epithelial ovarian cancer.
Cobellis L; Reis FM; Luisi S; Danero S; Pirtoli L; Scambia G; Petraglia F
J Soc Gynecol Investig; 2004 May; 11(4):203-6. PubMed ID: 15120692
[TBL] [Abstract][Full Text] [Related]
42. Germ cell tumors of the gonads: a selective review emphasizing problems in differential diagnosis, newly appreciated, and controversial issues.
Ulbright TM
Mod Pathol; 2005 Feb; 18 Suppl 2():S61-79. PubMed ID: 15761467
[TBL] [Abstract][Full Text] [Related]
43. [Differential cytologic diagnosis of serous and mucinous ovarian tumors].
Agamova KA; Gladunova ZD; Nikitina NI
Lab Delo; 1986; (2):77-9. PubMed ID: 2421066
[No Abstract] [Full Text] [Related]
44. TPS and CA 125 levels in serum, cyst fluid and ascites of patients with epithelial ovarian neoplasms.
Harłozinska A; Sedlaczek P; Van Dalen A; Rozdolski K; Einarsson R
Anticancer Res; 1997; 17(6D):4473-8. PubMed ID: 9494553
[TBL] [Abstract][Full Text] [Related]
45. [Serous papillary cystadenoma of the rectum].
Karseladze AI; Vinogradov AL
Arkh Patol; 1985; 47(11):71-4. PubMed ID: 4091700
[TBL] [Abstract][Full Text] [Related]
46. Neurohormonal peptide immunoreactive cells in mucinous cystadenomas and cystadenocarcinomas of the ovary.
Sporrong B; Alumets J; Clase L; Falkmer S; Håkanson R; Ljungberg O; Sundler F
Virchows Arch A Pathol Anat Histol; 1981; 392(3):271-80. PubMed ID: 6115500
[No Abstract] [Full Text] [Related]
47. Prostate-derived Ets factor is overexpressed in serous epithelial ovarian tumors.
Rodabaugh KJ; Mhawech-Fauceglia P; Groth J; Lele S; Sood AK
Int J Gynecol Pathol; 2007 Jan; 26(1):10-5. PubMed ID: 17197890
[TBL] [Abstract][Full Text] [Related]
48. [Serous and mucinous ovarian cystadenomas at the limit of malignancy].
Chenevart P; Gloor E
Schweiz Med Wochenschr; 1980 Apr; 110(14):531-9. PubMed ID: 7375903
[TBL] [Abstract][Full Text] [Related]
49. Ovarian carcinoma cells and IL-1beta-activated human peritoneal mesothelial cells are possible sources of vascular endothelial growth factor in inflammatory and malignant peritoneal effusions.
Stadlmann S; Amberger A; Pollheimer J; Gastl G; Offner FA; Margreiter R; Zeimet AG
Gynecol Oncol; 2005 Jun; 97(3):784-9. PubMed ID: 15943987
[TBL] [Abstract][Full Text] [Related]
50. [Expression of the cdx2 gene in benign intestinal-type mucinous ovarian tumors].
Gaggero G; Sola S; Mora M; Fulcheri E
Pathologica; 2003 Aug; 95(4):185-91. PubMed ID: 14577202
[TBL] [Abstract][Full Text] [Related]
51. [Cytophotometric determination of DNA concentration in the process of malignant degeneration of serous ovarian cysts].
Irzhanov SI
Vopr Onkol; 1971; 17(3):52-4. PubMed ID: 5563178
[No Abstract] [Full Text] [Related]
52. Gonadotropin (LH, FSH) levels in serum and cyst fluid in epithelial tumors of the ovary.
Chudecka-Głaz A; Rzepka-Górska I; Kosmowska B
Arch Gynecol Obstet; 2004 Nov; 270(3):151-6. PubMed ID: 12883823
[TBL] [Abstract][Full Text] [Related]
53. [Diagnostic significance of ferritin assay in peritoneal fluid and gastric juice].
Krylov IuV; Malashenko SV; Medvedev MN; Mikhaĭlova EI
Vopr Onkol; 2002; 48(1):88-90. PubMed ID: 12101576
[TBL] [Abstract][Full Text] [Related]
54. Value of ascitic fluid ferritin in the differential diagnosis of malignant ascites.
Kountouras J; Boura P; Tsapas G; Charisis K; Magoula I; Tsakiri I
Anticancer Res; 1993; 13(6B):2441-5. PubMed ID: 8135481
[TBL] [Abstract][Full Text] [Related]
55. Ultrastructural study of benign, low-malignant potential (LMP), and malignant ovarian tumors.
Ishioka S; Sagae S; Ito E; Kudo R
Med Electron Microsc; 2004 Mar; 37(1):37-44. PubMed ID: 15057603
[TBL] [Abstract][Full Text] [Related]
56. Soluble receptor for urokinase plasminogen activator in both full-length and a cleaved form is present in high concentration in cystic fluid from ovarian cancer.
Wahlberg K; Høyer-Hansen G; Casslén B
Cancer Res; 1998 Aug; 58(15):3294-8. PubMed ID: 9699658
[TBL] [Abstract][Full Text] [Related]
57. Immunohistochemical similarities between pancreatic mucinous cystic tumor and ovarian mucinous cystic tumor.
Suzuki Y; Sugiyama M; Abe N; Fujioka Y; Atomi Y
Pancreas; 2008 Jan; 36(1):e40-6. PubMed ID: 18192871
[TBL] [Abstract][Full Text] [Related]
58. Morphological and immunological heterogeneity of human ovarian neoplasms.
Harłozińska A; Rabczyński J; Bar JK; Richter R
Arch Immunol Ther Exp (Warsz); 1991; 39(4):419-29. PubMed ID: 1821619
[TBL] [Abstract][Full Text] [Related]
59. Fibrin-fibronectin compounds in human ovarian tumor ascites and their possible relation to the tumor stroma.
Wilhelm O; Hafter R; Coppenrath E; Pflanz MA; Schmitt M; Babic R; Linke R; Gössner W; Graeff H
Cancer Res; 1988 Jun; 48(12):3507-14. PubMed ID: 3130986
[TBL] [Abstract][Full Text] [Related]
60. Ovarian giant cell tumor with cystadenocarcinoma.
Veliath AJ; Sankaran V; Aurora AL
Arch Pathol; 1975 Sep; 99(9):488-91. PubMed ID: 1164251
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]